Evidence map›Paper›PMID 34151147›Full record

ArticleAccess microbiology2021

Claudia M Barberis, Germán M Traglia, Marisa N Almuzara, Danilo J P G Rocha, Carolina S Santos, Eric R G R Aguiar, Luis G C Pacheco, Carlos A Vay

Open access · goldAbstract readCase Reports
In one paragraph

Article in Access microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. An underestimated pathogen:Journal of clinical microbiology · 2025
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Claudia M BarberisUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires, Argentina.
Germán M TragliaUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-4780-5311
Marisa N AlmuzaraUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires, Argentina.
Danilo J P G RochaInstituto de Ciencias da Saúde, Universidade Federal da Bahia, Salvador-BA, Brasil.ORCID https://orcid.org/0000-0002-2160-2153
Carolina S SantosInstituto de Ciencias da Saúde, Universidade Federal da Bahia, Salvador-BA, Brasil.
Eric R G R AguiarInstituto de Ciencias da Saúde, Universidade Federal da Bahia, Salvador-BA, Brasil.ORCID https://orcid.org/0000-0002-8143-5756
Luis G C PachecoInstituto de Ciencias da Saúde, Universidade Federal da Bahia, Salvador-BA, Brasil.
Carlos A VayUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Ciudad Autónoma de Buenos Aires, Argentina.
Universidad de Buenos Aires · ARUniversidade Federal da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CorynebacteriumMALDI-TOF MSurinary tract infection

Identifiers

PMID34151147
PMCPMC8209636
OpenAlexW3122780295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.